Kazia Therapeutics (KZIA) Equity Ratio (2017 - 2025)
Kazia Therapeutics (KZIA) has disclosed Equity Ratio for 4 consecutive years, with 0.46 as the latest value for Q2 2024.
- For the quarter ending Q2 2024, Equity Ratio fell 208.16% year-over-year to 0.46, compared with a TTM value of 0.43 through Jun 2023, changed N/A, and an annual FY2024 reading of 0.46, down 208.16% over the prior year.
- Equity Ratio was 0.46 for Q2 2024 at Kazia Therapeutics, down from 0.43 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.43 in Q2 2023 and bottomed at 0.46 in Q2 2024.